These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis. Sørensen HT; Jacobsen J; Nørgaard M; Pedersen L; Johnsen SP; Baron JA Aliment Pharmacol Ther; 2006 Jul; 24(1):111-6. PubMed ID: 16803609 [TBL] [Abstract][Full Text] [Related]
29. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos. Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111 [TBL] [Abstract][Full Text] [Related]
30. No association between gastroesophageal reflux and cancers of the larynx and pharynx. Nilsson M; Chow WH; Lindblad M; Ye W Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1194-7. PubMed ID: 15894671 [TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment of gastroesophageal reflux disease in Ohio Medicaid patients: practice patterns and temporal trends. Cooper GS; Mourad WA; Koroukian SM Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):21-7. PubMed ID: 14971119 [TBL] [Abstract][Full Text] [Related]
32. Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based study. Jansson C; Nordenstedt H; Wallander MA; Johansson S; Johnsen R; Hveem K; Lagergren J Aliment Pharmacol Ther; 2008 Jan; 27(1):58-65. PubMed ID: 17919274 [TBL] [Abstract][Full Text] [Related]
33. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110 [TBL] [Abstract][Full Text] [Related]
34. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study. Andersen AB; Erichsen R; Farkas DK; Mehnert F; Ehrenstein V; Sørensen HT Aliment Pharmacol Ther; 2012 May; 35(10):1190-8. PubMed ID: 22443179 [TBL] [Abstract][Full Text] [Related]
35. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806 [TBL] [Abstract][Full Text] [Related]
36. Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case-control study. Ljung R; Lagergren J; Bexelius TS; Mattsson F; Lindblad M Gut; 2012 Jun; 61(6):873-6. PubMed ID: 21957155 [TBL] [Abstract][Full Text] [Related]
38. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux. Miner PB Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267 [TBL] [Abstract][Full Text] [Related]
39. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Bermejo F; Lopez-Sanroman A; Taxonera C; Gisbert JP; Pérez-Calle JL; Vera I; Menchén L; Martín-Arranz MD; Opio V; Carneros JA; Van-Domselaar M; Mendoza JL; Luna M; López P; Calvo M; Algaba A Aliment Pharmacol Ther; 2008 Sep; 28(5):623-8. PubMed ID: 18513380 [TBL] [Abstract][Full Text] [Related]
40. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]